Premium
DRP1 upregulation promotes pancreatic cancer growth and metastasis through increased aerobic glycolysis
Author(s) -
Liang Jing,
Yang Yiping,
Bai Lu,
Li Feng,
Li Enxiao
Publication year - 2020
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1111/jgh.14912
Subject(s) - downregulation and upregulation , mitochondrial fission , mitochondrial fusion , anaerobic glycolysis , cancer research , cell growth , microbiology and biotechnology , biology , mitochondrion , pancreatic cancer , cancer cell , medicine , cancer , mitochondrial dna , biochemistry , gene , genetics
Background Mitochondrial shape is dynamically changed by fusion and fission processes in cells, and dysfunction of this process has become one of the emerging hallmarks of cancer. However, the expression patterns and biological effects of mitochondrial fission and fusion proteins in pancreatic cancer (PC) are still unclear. Methods The expressions of mitochondrial fission and fusion proteins were first evaluated by quantitative reverse transcription polymerase chain reaction and western blot analysis in both PC cell lines and tissue samples. In addition, the biologic functions of the differentially expressed proteins in PC cell growth and metastasis both in vitro and in vivo and their potential underlying mechanisms were systematically explored. Results We first found that DRP1 was substantially upregulated in PC cell lines and tissue samples mainly due to the downregulation of miR‐29a, which contributed to the poor survival of PC patients. DRP1 promoted the growth and metastasis of PC cells both in vitro and in vivo by inducing G1‐S cell cycle transition and matrix metalloproteinase 2 secretion. Mechanistic investigations revealed that increased DRP1 upregulation‐mediated mitochondrial fission and subsequently enhanced aerobic glycolysis were involved in the promotion of growth and metastasis by DRP1 in PC cells. Conclusions Our findings demonstrate that mitochondrial fusion protein DRP1 plays a critical oncogenic role in PC cells by enhancing aerobic glycolysis, which could serve as a novel therapeutic target for PC treatment.